New antifungal agents and preparations
Author:
- 1 October 2000
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 16 (2) , 147-150
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Current and Emerging Azole Antifungal AgentsClinical Microbiology Reviews, 1999
- An EORTC International Multicenter Randomized Trial (EORTC Number 19923) Comparing Two Dosages of Liposomal Amphotericin B for Treatment of Invasive AspergillosisClinical Infectious Diseases, 1998
- Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infectionsBritish Journal of Haematology, 1998
- Lipid Formulations of Amphotericin B: Clinical Efficacy and ToxicitiesClinical Infectious Diseases, 1998
- International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal InfectionsClinical Infectious Diseases, 1997
- Use of amphotericin B with azole antifungal drugs: what are we doing?Antimicrobial Agents and Chemotherapy, 1995
- A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without NeutropeniaNew England Journal of Medicine, 1994
- Oral Azole Drugs as Systemic Antifungal TherapyNew England Journal of Medicine, 1994
- Systemically Administered Antifungal AgentsDrugs, 1992
- Current Role of Therapy with Amphotericin BClinical Infectious Diseases, 1992